Reference

CEM_CMO(2021)022

Name

COVID therapeutic alert – interim clinical commissioning policy on the use of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19

Categories

Scottish Government CMO Letters

Organization

Scottish Government Health and Social Care Directorates

Keywords

NHS SCOTLAND COVID-19 CORONAVIRUS TREATMENTS DRUGS IMMUNISATION PATIENTS HEALTHCARE PROFESSIONALS

Description

Please see below CMO letter and interim clinical commissioning policy regarding the use of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 for dissemination to relevant healthcare professionals.

Contact Name

Irene Fazakerley

Contact Email

Contact Address

Contact Phone

Created

2021-12-16 00:00:00

Download URL